findmyKOL

Dean Kirkel, MD

Basic profile

WellStar Health System

ORCIDNone on fileNPI
RegionMarietta, GA · SoutheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Dean Kirkel is an Oncology physician affiliated with WellStar Health System. OpenAlex indexes 10 publications with 659 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10publications

Distinct works indexed by OpenAlex.

659citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
22companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

340 Kennestone Hospital Blvd Ste 100
Marietta, GA 300601158

Telephone

770-281-5100

Registry record last updated 10 Jun 2019.

View the NPPES registry record

Industry payments

22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    34.1%
    Opioid Agonist16.7%
    Oxycodone Hcl40%Oxycodone-Acetaminophen20%Fentanyl15%Morphine Sulfate Er10%Tramadol Hcl10%Hydromorphone Hcl4%
    Part D<11 patients
    Atypical Antipsychotic4.4%
    Olanzapine100%
    Part D26 patients

    + 7 more classes in this area

  • Cancer & immunology

    25.5%
    Aromatase Inhibitor11.4%
    Letrozole57%Anastrozole36%Exemestane7%
    Part D<11 patients
    Thalidomide Analog3.3%
    Revlimid77%Pomalyst23%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    9.3%
    Serotonin-3 Receptor Antagonist4.9%
    Ondansetron Hcl100%
    Part D51 patients
    Corticosteroid2.5%
    Prednisone100%
    Part D23 patients

    + 3 more classes in this area

Where care is delivered (Part B)5.9% facility · 94.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”